Suppliers / Ferron Par Pharmaceuticals

Ferron Par Pharmaceuticals

Indonesia Updated 9 July 2026

Ferron Par Pharmaceuticals is a finished-dose manufacturer based in Indonesia. It appears in 171 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $1.2M of exports covering 21 molecules to 2 destinations in 2025.

0
active US DMFs
0
valid CEPs
2
registered plants
171
filings across 1 regulators

Registered plants

Site FDA FEI
KAB. BEKASI, Indonesia Not on file
-, Indonesia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
BPOM (ID) 171 None

Scale

Year Revenue Exports Destinations
2025 Not reported $1.2M 2
2024 Not reported $283K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Ferron Par Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts